MedPath

ComVi and D-type Stent in Malignant GOO

Not Applicable
Completed
Conditions
Gastric Outlet Obstruction
Interventions
Device: uncovered D-type stent insertion
Device: double-layered ComVi stent insertion
Registration Number
NCT01839292
Lead Sponsor
Ajou University School of Medicine
Brief Summary

Covered self-expandable metallic stents (SEMS) have been used to prevent tumor ingrowth, a common complication of uncovered SEMSs. However, they have revealed a high incidence of stent migration in patients with unresectable malignant gastric outlet obstruction (GOO). A conformable covered SEMS was introduced to overcome both stent migration and tumor ingrowth. The aims of this study were to evaluate the clinical outcomes of newly designed conformable covered and uncovered SEMS for palliation of malignant GOO.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria
  • adults 18 years of age or older
  • obstructive symptoms due to unresectable malignant GOO
  • a Karnofsky performance score of more than 30 (13)
Exclusion Criteria
  • history of a previous SEMS insertion
  • the presence of obstruction in the gastrointestinal tract excluding the gastric outlet
  • severe comorbidities precluding the endoscopic procedure, such as cardiopulmonary disease, sepsis, and bleeding disorders
  • a life expectancy of less than 1 month after SEMS insertion
  • history of gastric surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
uncovered D-type stentuncovered D-type stent insertionuncovered D-type stent, which effectively reduces stent migration, especially in malignant colorectal obstruction
double-layered ComVi stentdouble-layered ComVi stent insertiondouble-layered ComVi stent, which is a modified covered stent with an additional outer bare wire mesh to overcome both tumor ingrowth and stent migration
Primary Outcome Measures
NameTimeMethod
the stent patency time from stent insertion to restenosis due to stent malfunction or deathUp to 1 years
Secondary Outcome Measures
NameTimeMethod
stent malfunction (e.g., stent migration or occlusion due to tumor ingrowth/overgrowth) and the reintervention rateup to 1 years

Trial Locations

Locations (1)

Ajou University Hospital

🇰🇷

Suwon, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath